Literature DB >> 31625206

Efficient production of gamma-aminobutyric acid by engineered Saccharomyces cerevisiae with glutamate decarboxylases from Streptomyces.

Haina Yuan1,2, Wei Zhang3, Gongnian Xiao1, Jixun Zhan2.   

Abstract

Gamma-aminobutyric acid (GABA) is an industrially valuable natural product. This study was aimed to establish an efficient food-grade production process of GABA by engineering Saccharomyces cerevisiae that is generally recognized as safe (GRAS). GABA can be produced by catalytic decarboxylation of l-glutamate (l-Glu) by glutamate decarboxylase (GAD, EC4.1.1.15). Two GADs, SsGAD from Streptomyces sp. MJ654-NF4 and ScGAD from Streptomyces chromofuscus ATCC 49982, were heterologously expressed in S. cerevisiae BJ5464. The engineered yeast strains were used as whole-cell biocatalysts for GABA production. S. cerevisiae BJ5464/SsGAD exhibited significantly higher efficient catalytic activity than that of S. cerevisiae BJ5464/ScGAD. The optimal bioconversion system consisted of a cell density of OD600 30, 0.1 M l-Glu, and 0.28 mM pyridoxal phosphate in 0.2 M Na2 HPO4 -citric acid buffer with pH 5.4, and the reactions were performed at 50 °C for 12 H. S. cerevisiae BJ5464/SsGAD cells can be reused, and the accumulated GABA titer reached 62.6 g/L after 10 batches with an overall molar conversion rate of 60.8 mol%. This work thus provides an effective production process of GABA using engineered yeast for food and pharmaceutical applications.
© 2019 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Saccharomyces cerevisiae; gamma-aminobutyric acid; glutamate decarboxylase; heterologous expression; whole-cell bioconversion

Mesh:

Substances:

Year:  2019        PMID: 31625206     DOI: 10.1002/bab.1840

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  1 in total

Review 1.  Streptomycetes as platform for biotechnological production processes of drugs.

Authors:  Simona Barbuto Ferraiuolo; Marcella Cammarota; Chiara Schiraldi; Odile Francesca Restaino
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.